[an error occurred while processing this directive]

高等学校化学研究 ›› 2001, Vol. 17 ›› Issue (S1): 110-110.

• Articles • 上一篇    下一篇

SAR by MS

HOFSTADLER Steven, LOWERY Kristin, DRADER Jared, DING Yi-li, JEFFERSON Elizabeth, SWAYZE Eric, GRIFFEY Rich, HE Yun   

  1. Ibis Therapeutics, A Division of Isis Pharmaceuticals, Inc. 2292 Faraday Av., Carlsbad, CA 92008
  • 出版日期:2001-12-31 发布日期:2016-03-14
  • 通讯作者: HE Yun,E-mail:yhe@isisph.com E-mail:yhe@isisph.com

SAR by MS

HOFSTADLER Steven, LOWERY Kristin, DRADER Jared, DING Yi-li, JEFFERSON Elizabeth, SWAYZE Eric, GRIFFEY Rich, HE Yun   

  1. Ibis Therapeutics, A Division of Isis Pharmaceuticals, Inc. 2292 Faraday Av., Carlsbad, CA 92008
  • Online:2001-12-31 Published:2016-03-14
  • Contact: HE Yun,E-mail:yhe@isisph.com E-mail:yhe@isisph.com

PDF (PC)

被引次数

1

摘要：

RNAs have recently emerged as an exciting new target for small molecule therapeutics.Conventional HTS discovery strategics measuring disruption of RNA-protein interactions have proven unsuccessful.

Abstract:

RNAs have recently emerged as an exciting new target for small molecule therapeutics.Conventional HTS discovery strategics measuring disruption of RNA-protein interactions have proven unsuccessful.